Matches in Wikidata for { <http://www.wikidata.org/entity/Q89983190> ?p ?o ?g. }
- Q89983190 description "2020 nî lūn-bûn" @default.
- Q89983190 description "2020年の論文" @default.
- Q89983190 description "2020年学术文章" @default.
- Q89983190 description "2020年学术文章" @default.
- Q89983190 description "2020年学术文章" @default.
- Q89983190 description "2020年学术文章" @default.
- Q89983190 description "2020年学术文章" @default.
- Q89983190 description "2020年学术文章" @default.
- Q89983190 description "2020年學術文章" @default.
- Q89983190 description "2020年學術文章" @default.
- Q89983190 description "2020年學術文章" @default.
- Q89983190 description "2020年學術文章" @default.
- Q89983190 description "2020年學術文章" @default.
- Q89983190 description "2020년 논문" @default.
- Q89983190 description "article científic" @default.
- Q89983190 description "article scientific" @default.
- Q89983190 description "article scientifique" @default.
- Q89983190 description "articol științific" @default.
- Q89983190 description "articolo scientifico" @default.
- Q89983190 description "artigo científico" @default.
- Q89983190 description "artigo científico" @default.
- Q89983190 description "artigo científico" @default.
- Q89983190 description "artikel ilmiah" @default.
- Q89983190 description "artikull shkencor" @default.
- Q89983190 description "artikulong pang-agham" @default.
- Q89983190 description "artykuł naukowy" @default.
- Q89983190 description "artículo científico publicado en 2020" @default.
- Q89983190 description "artículu científicu" @default.
- Q89983190 description "bilimsel makale" @default.
- Q89983190 description "bài báo khoa học" @default.
- Q89983190 description "naučni članak" @default.
- Q89983190 description "scienca artikolo" @default.
- Q89983190 description "scientific article published on 02 March 2020" @default.
- Q89983190 description "scientific article published on 2 March 2020" @default.
- Q89983190 description "scientific article published on 2 March 2020" @default.
- Q89983190 description "teaduslik artikkel" @default.
- Q89983190 description "tieteellinen artikkeli" @default.
- Q89983190 description "tudományos cikk" @default.
- Q89983190 description "vedecký článok" @default.
- Q89983190 description "vetenskaplig artikel" @default.
- Q89983190 description "videnskabelig artikel udgivet 2. marts 2020" @default.
- Q89983190 description "vitenskapelig artikkel" @default.
- Q89983190 description "vitskapeleg artikkel" @default.
- Q89983190 description "vědecký článek" @default.
- Q89983190 description "wetenschappelijk artikel" @default.
- Q89983190 description "wissenschaftlicher Artikel" @default.
- Q89983190 description "επιστημονικό άρθρο" @default.
- Q89983190 description "мақолаи илмӣ" @default.
- Q89983190 description "наукова стаття, опублікована в березні 2020" @default.
- Q89983190 description "научна статия" @default.
- Q89983190 description "научная статья" @default.
- Q89983190 description "научни чланак" @default.
- Q89983190 description "научни чланак" @default.
- Q89983190 description "מאמר מדעי" @default.
- Q89983190 description "مقالة علمية نشرت في 2 مارس 2020" @default.
- Q89983190 description "২ মার্চ ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89983190 description "บทความทางวิทยาศาสตร์" @default.
- Q89983190 description "სამეცნიერო სტატია" @default.
- Q89983190 name "Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu" @default.
- Q89983190 name "Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu" @default.
- Q89983190 type Item @default.
- Q89983190 label "Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu" @default.
- Q89983190 label "Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu" @default.
- Q89983190 prefLabel "Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu" @default.
- Q89983190 prefLabel "Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu" @default.
- Q89983190 P1433 Q89983190-028E30AB-F2C3-4312-B663-BFD53D6DC5EE @default.
- Q89983190 P1476 Q89983190-20CE9F06-19D9-4AA2-94F7-813A571BD21F @default.
- Q89983190 P2093 Q89983190-B92A9BA8-4FD3-4021-9F63-CF69294C4615 @default.
- Q89983190 P2860 Q89983190-1A1BDEC2-6115-4123-8CE0-2FE60508D5AE @default.
- Q89983190 P2860 Q89983190-33B1E292-7AC7-429D-9201-1B5A60993BF2 @default.
- Q89983190 P2860 Q89983190-3C8945D5-E1FF-499B-8670-DEDD5350A532 @default.
- Q89983190 P2860 Q89983190-5B5D2617-FE85-4EAB-BD9D-A11F8E230525 @default.
- Q89983190 P2860 Q89983190-649BDF8D-F8D0-4ED2-8F41-5CB9B7D5496D @default.
- Q89983190 P2860 Q89983190-68563261-961F-4ACF-8BED-9100DA0C18B8 @default.
- Q89983190 P2860 Q89983190-A38241B5-174D-4303-8F4D-1EBDDDC5345E @default.
- Q89983190 P2860 Q89983190-AE59863C-C65B-4055-8013-4CE93E9A9A1B @default.
- Q89983190 P2860 Q89983190-E539D18B-6304-4FD0-A421-82552777DCDB @default.
- Q89983190 P2860 Q89983190-F09D82A4-440A-452F-8E7A-694A753616AE @default.
- Q89983190 P304 Q89983190-970AA5F9-650B-454E-B5DA-5226C10B5704 @default.
- Q89983190 P31 Q89983190-6DC619D5-614C-4045-9487-CD75810CD8AE @default.
- Q89983190 P356 Q89983190-4CD2D917-1507-4E6D-ADF4-C28201D399A4 @default.
- Q89983190 P433 Q89983190-4BF9C256-7A65-429B-9275-D7AAD2F396A5 @default.
- Q89983190 P478 Q89983190-8F7908DA-7094-4448-966E-401F118A6324 @default.
- Q89983190 P50 Q89983190-2BC52408-5A5F-4350-81E2-8F7020F793E1 @default.
- Q89983190 P50 Q89983190-2D7CD12D-41BD-44D2-A483-229C82405589 @default.
- Q89983190 P50 Q89983190-32FF7D13-8B46-48E9-BCCC-7C0A2DB16D29 @default.
- Q89983190 P50 Q89983190-45066421-6C1A-443F-9B5F-99A5784240ED @default.
- Q89983190 P50 Q89983190-6C28110B-E8C7-499A-93B0-25827111FC85 @default.
- Q89983190 P50 Q89983190-6FDA1344-46DD-446E-8228-559C3C8CAB3F @default.
- Q89983190 P50 Q89983190-7470439A-ABA4-4A7D-8B08-2714D46ED9A1 @default.
- Q89983190 P50 Q89983190-86A6B3DB-1323-457B-BA82-39D449113D11 @default.
- Q89983190 P50 Q89983190-8811003A-1B9E-4FD6-9B26-DF81D6AAED49 @default.
- Q89983190 P50 Q89983190-97D5594C-E63A-4922-9F62-84B5B7689A70 @default.
- Q89983190 P50 Q89983190-98711510-FBF9-4877-BC97-643E4393EA35 @default.
- Q89983190 P50 Q89983190-A24989DC-CAD2-414A-9B39-27BB40FD1E2B @default.
- Q89983190 P50 Q89983190-CDE96BDC-E5F1-46DE-9ED1-08DD2AB50915 @default.
- Q89983190 P577 Q89983190-33469561-F8C0-476D-9716-1F4E0E7A34A6 @default.
- Q89983190 P698 Q89983190-FFA13500-BFF2-48F9-A668-6E95C5E6AC44 @default.
- Q89983190 P921 Q89983190-D2502943-CF29-45B6-8328-1FC5E6CD1B6A @default.
- Q89983190 P932 Q89983190-E9E98A45-4D3D-4D90-B193-F7A0E1DBDE63 @default.